Avanos Medical (AVNS) EBIT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 51.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.23% |
| Dec 31, 2025 | -46.80% |
| Sep 30, 2025 | -80.16% |
| Jun 30, 2025 | -110.87% |
| Mar 31, 2025 | 6.20% |
| Dec 31, 2024 | -165.35% |
| Sep 30, 2024 | 52.25% |
| Jun 30, 2024 | 42.00% |
| Mar 31, 2024 | 32.43% |
| Dec 31, 2023 | 30.79% |
| Sep 30, 2023 | 141.01% |
| Jun 30, 2023 | -5.27% |
| Mar 31, 2023 | -130.00% |
| Dec 31, 2022 | 92.99% |
| Sep 30, 2022 | 39.37% |
| Jun 30, 2022 | 44.71% |
| Mar 31, 2022 | 32.94% |
| Dec 31, 2021 | -39.23% |
| Sep 30, 2021 | -21.39% |
| Jun 30, 2021 | -41.44% |
| Mar 31, 2021 | -21.00% |
| Dec 31, 2020 | -150.58% |
| Sep 30, 2020 | 78.74% |
| Jun 30, 2020 | 47.01% |
| Mar 31, 2020 | 26.70% |
| Dec 31, 2019 | 73.84% |
| Sep 30, 2019 | -42.05% |
| Jun 30, 2019 | -36.74% |
| Mar 31, 2019 | -39.99% |
| Dec 31, 2018 | -26.65% |
| Sep 30, 2018 | 26.31% |
| Jun 30, 2018 | -26.43% |
| Mar 31, 2018 | -29.49% |
| Dec 31, 2017 | -28.56% |
| Sep 30, 2017 | -40.84% |
| Jun 30, 2017 | -39.06% |
| Mar 31, 2017 | -31.72% |
| Dec 31, 2016 | -72.16% |
| Sep 30, 2016 | -33.26% |